StonvexLoading…
StonvexStonvexStonvexCore line items from MSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-30 | Annual 2024 2024-08-31 | Annual 2023 2023-09-02 | Annual 2022 2022-09-03 |
|---|---|---|---|---|
Revenue | $3.77B | $3.82B | $4.01B | $3.69B |
Operating Income | $301.56M | $390.39M | $483.73M | $468.71M |
Net Income | $199.33M | $258.59M | $343.23M | $339.79M |
EPS (Diluted) | $3.57 | $4.58 | $6.11 | $6.06 |
Total Assets | $2.46B | $2.46B | $2.54B | $2.73B |
Total Liabilities | $1.07B | $1.06B | $1.05B | $1.37B |
Cash & Equivalents | $56.23M | $29.59M | $50.05M | $43.54M |
Free Cash Flow OCF − CapEx | $240.88M | $311.29M | $607.09M | $184.81M |
Shares Outstanding | 55.89M | 56.44M | 56.21M | 56.05M |